SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kazuo Notsumata, Tatsuo Kumai, Teruyuki Ueda, Hisato Matsuda, Taku Sanada, Hirokazu Shin, Hiroyuki Watanabe, Daisyu Toya, Nobuyoshi Tanaka, Hiroyuki Igarashi, Masaki Sano, Yuichi Nushimo, Automated risk management of HBV reactivation by encoding patients^|^apos; medical records, Kanzo, 2014, 55, 2, 91

    CrossRef

  2. 2
    Brian J. McMahon, Chronic Hepatitis B Virus Infection, Medical Clinics of North America, 2014, 98, 1, 39

    CrossRef

  3. 3
    Liang-He Yu, Nan Li, Jie Shi, Wei-Xing Guo, Meng-Chao Wu, Shu-Qun Cheng, Does Anti-HBV Therapy Benefit the Prognosis of HBV-Related Hepatocellular Carcinoma Following Hepatectomy?, Annals of Surgical Oncology, 2014, 21, 3, 1010

    CrossRef

  4. 4
    Mehmet A.N. Sendur, Nurullah Zengin, Sercan Aksoy, Kadri Altundag, Everolimus: a new hope for patients with breast cancer, Current Medical Research and Opinion, 2014, 30, 1, 75

    CrossRef

  5. 5
    Kiran Motaparthi, Vladimir Stanisic, Abby S. Van Voorhees, Mark G. Lebwohl, Sylvia Hsu, From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti–tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis, Journal of the American Academy of Dermatology, 2014, 70, 1, 178

    CrossRef

  6. You have free access to this content6
    JSH Guidelines for the Management of Hepatitis B Virus Infection, Hepatology Research, 2014, 44,
  7. 7
    Gang Huang, Wan Yee Lau, Feng Shen, Ze-ya Pan, Si-yuan Fu, Yun Yang, Wei-ping Zhou, Meng-chao Wu, Preoperative Hepatitis B Virus DNA Level is a Risk Factor for Postoperative Liver Failure in Patients Who Underwent Partial Hepatectomy for Hepatitis B-Related Hepatocellular Carcinoma, World Journal of Surgery, 2014,

    CrossRef

  8. 8
    Wei Huang, Wei Zhang, Min Fan, Yanda Lu, Jian Zhang, Hongsheng Li, Baosheng Li, Risk factors for hepatitis B virus reactivation after conformal radiotherapy in patients with hepatocellular carcinoma, Cancer Science, 2014, 105, 4
  9. 9
    Rongjuan Pei, Sebastian Grund, Jens Verheyen, Stefan Esser, Xinwen Chen, Mengji Lu, Spontaneous reactivation of hepatitis B virus replication in an HIV coinfected patient with isolated anti-Hepatitis B core antibodies, Virology Journal, 2014, 11, 1, 9

    CrossRef

  10. 10
    A. Mekkaoui, Z. Benbrahim, O. Mesbahi, A. Ibrahimi, N. Aqodad, Traitement préemptif de la réactivation de l’hépatite virale B des patients sous chimiothérapie anticancéreuse, Journal Africain du Cancer / African Journal of Cancer, 2014, 6, 1, 47

    CrossRef

  11. 11
    Pankaj Puri, Acute Exacerbation of Chronic Hepatitis B: The Dilemma of Differentiation from Acute Viral Hepatitis B, Journal of Clinical and Experimental Hepatology, 2013, 3, 4, 301

    CrossRef

  12. 12
    Xiang-Ming Lao, Guangyu Luo, Liang-Tao Ye, Cheng Luo, Ming Shi, Dian Wang, Rongping Guo, Minshan Chen, Shengping Li, Xiaojun Lin, Yunfei Yuan, Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma, Liver International, 2013, 33, 4
  13. 13
    Fei W. Chen, Luke Coyle, Brett E. Jones, Venessa Pattullo, Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease, Liver International, 2013, 33, 8
  14. 14
    Mario Mandalà, Stefano Fagiuoli, Daniela Francisci, Raffaele Bruno, Barbara Merelli, Luisa Pasulo, Carlo Tondini, Roberto Labianca, Fausto Roila, Hepatitis B in immunosuppressed cancer patients: Pathogenesis, incidence and prophylaxis, Critical Reviews in Oncology/Hematology, 2013, 87, 1, 12

    CrossRef

  15. 15
    Juan Li, Junru Liu, Beihui Huang, Dong Zheng, Mei Chen, Zhenhai Zhou, Duorong Xu, Waiyi Zou, Hepatitis B virus infection status is an independent risk factor for multiple myeloma patients after autologous hematopoietic stem cell transplantation, Tumor Biology, 2013, 34, 3, 1723

    CrossRef

  16. 16
    J.-Q. Dan, Y.-J. Zhang, J.-T. Huang, M.-S. Chen, H.-J. Gao, Z.-W. Peng, L. Xu, W.Y. Lau, Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: A retrospective study, European Journal of Surgical Oncology (EJSO), 2013, 39, 8, 865

    CrossRef

  17. 17
    Winnie Yeo, Henry LY Chan, Hepatitis B virus reactivation associated with anti-neoplastic therapy, Journal of Gastroenterology and Hepatology, 2013, 28, 1
  18. 18
    Oguz Durmus, Levent Tekin, Alparslan Bayram Carli, Engin Cakar, Ali Acar, Asim Ulcay, Umit Dincer, Mehmet Zeki Kiralp, Hepatitis B virus reactivation in a Juvenile Rheumatoid arthritis patient under treatment and its successful management: a complicated case, Rheumatology International, 2013, 33, 5, 1345

    CrossRef

  19. 19
    Seok Jin Kim, Chiun Hsu, Yu-Qin Song, Kevin Tay, Xiao-Nan Hong, Junning Cao, Jin Seok Kim, Hyeon Seok Eom, Joon Hyeok Lee, Jun Zhu, Kian-Meng Chang, Arry Harryanto Reksodiputro, Daryl Tan, Yeow Tee Goh, Jejung Lee, Tanin Intragumtornchai, Wee-Joo Chng, Ann-Lii Cheng, Soon Thye Lim, Cheolwon Suh, Yok-Lam Kwong, Won Seog Kim, Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group, European Journal of Cancer, 2013, 49, 16, 3486

    CrossRef

  20. 20
    Chun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao, Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management, Hepatology International, 2013, 7, 2, 316

    CrossRef

  21. 21
    Ashish Goel, C. E. Eapen, Debashish Danda, Infliximab and occult Hepatitis B infection: to treat or not to treat?, International Journal of Rheumatic Diseases, 2013, 16, 4
  22. 22
    Michelle C.M. Cheung, Kosh Agarwal, Liver abnormalities in the immunosuppressed, Best Practice & Research Clinical Gastroenterology, 2013, 27, 4, 597

    CrossRef

  23. 23
    J.M. Kim, C.H.D. Kwon, J.-W. Joh, S.W.J. Ko, J.B. Park, S.J. Kim, J.-H. Lee, G.S. Kim, S.J. Kim, S.-K. Lee, Liver Transplantation in Lymphoma Patients With Hepatitis B Virus Reactivation, Transplantation Proceedings, 2013, 45, 8, 2988

    CrossRef

  24. 24
    Daryl Tan, Soo Yong Tan, Soon Thye Lim, Seok Jin Kim, Won-Seog Kim, Ranjana Advani, Yok-Lam Kwong, Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelines, The Lancet Oncology, 2013, 14, 12, e548

    CrossRef

  25. 25
    Jessica P. Hwang, Anna S.-F. Lok, Management of patients with hepatitis B who require immunosuppressive therapy, Nature Reviews Gastroenterology & Hepatology, 2013, 11, 4, 209

    CrossRef

  26. 26
    Tsutomu Nishida, Naoki Hiramatsu, Masao Mizuki, Izumi Nagatomo, Hiroshi Kida, Keiko Tazumi, Shinichiro Shinzaki, Masanori Miyazaki, Takayuki Yakushijin, Tomohide Tatsumi, Hideki Iijima, Shinichi Kiso, Tatsuya Kanto, Masahiko Tsujii, Tetsuo Takehara, Managing hepatitis B virus carriers with systemic chemotherapy or biologic therapy in the outpatient clinic, Hepatology Research, 2013, 43, 4
  27. 27
    Jaswinder Singh Sodhi, Nayeem Wani, Samoon Jeelani, Sajad Geelani, Fehmida Akhtar, Gul Javid, Gh Nabi Yattoo, Altaf Shah, Gh Mohd Gulzar, Mushtaq A. Khan, Shaheena Parveen, Riyaz-u Saif, Abid Showkat, Occult hepatitis B virus infection as a cause of posttransfusion hepatitis in patients with cancers, Indian Journal of Gastroenterology, 2013, 32, 5, 291

    CrossRef

  28. 28
    Gang Huang, Eric C. H. Lai, Wan Yee Lau, Wei-ping Zhou, Feng Shen, Ze-ya Pan, Si-yuan Fu, Meng-chao Wu, Posthepatectomy HBV Reactivation in Hepatitis B–Related Hepatocellular Carcinoma Influences Postoperative Survival in Patients With Preoperative Low HBV-DNA Levels, Annals of Surgery, 2013, 257, 3, 490

    CrossRef

  29. 29
    Yihu Zheng, Shengchu Zhang, Hooi Min Tan Grahn, Chao Ye, Zheng Gong, Qiyu Zhang, Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis, Hepatitis Monthly, 2013, 13, 4

    CrossRef

  30. 30
    M. Ikeda, Reactivation of Hepatitis B Virus in Patients Receiving Chemotherapy, Japanese Journal of Clinical Oncology, 2013, 43, 1, 8

    CrossRef

  31. You have free access to this content31
    Tsunamasa Watanabe, Yasuhito Tanaka, Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy, Hepatology Research, 2013, 43, 2
  32. 32
    Hua-Jie Dong, Ling-Na Ni, Gui-Feng Sheng, Hong-Lei Song, Jian-Zhong Xu, Yang Ling, Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: A meta-analysis, Journal of Clinical Virology, 2013, 57, 3, 209

    CrossRef

  33. 33
    Jessica P Hwang, Michael J Fisch, Anna S-F Lok, Hong Zhang, John M Vierling, Maria E Suarez-Almazor, Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center, BMC Cancer, 2013, 13, 1, 534

    CrossRef

  34. 34
    Sang Hyoung Park, Suk-Kyun Yang, Young-Suk Lim, Ju Hyun Shim, Dong-Hoon Yang, Kee Wook Jung, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Jin-Ho Kim, Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases, Inflammatory Bowel Diseases, 2012, 18, 11
  35. 35
    Fan Yang, Huan-Ling Zhu, Chuan He, Jian-Jun Li, Bing Xiang, Xu Cui, Jie Huang, Jie Ji, Hong-Bing Ma, Ting Liu, Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin’s Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study, Indian Journal of Hematology and Blood Transfusion, 2012,

    CrossRef

  36. 36
    Deborah Rund, Hepatitis B infection and myeloma in developing countries: therapeutic dilemmas, Leukemia & Lymphoma, 2012, 53, 2, 181

    CrossRef

  37. 37
    Jessica P. Hwang, John M. Vierling, Andrew D. Zelenetz, Susan C. Lackey, Rohit Loomba, Hepatitis B virus management to prevent reactivation after chemotherapy: a review, Supportive Care in Cancer, 2012, 20, 11, 2999

    CrossRef

  38. 38
    Yasunori Fujimoto, Naoya Hashimoto, Manabu Kinoshita, Yuko Miyazaki, Satoshi Tanaka, Takayuki Yakushijin, Tetsuo Takehara, Naoki Kagawa, Toshiki Yoshimine, Hepatitis B virus reactivation associated with temozolomide for malignant glioma: a case report and recommendation for prophylaxis, International Journal of Clinical Oncology, 2012, 17, 3, 290

    CrossRef

  39. 39
    KASL Clinical Practice Guidelines: Management of chronic hepatitis B, Clinical and Molecular Hepatology, 2012, 18, 2, 109

    CrossRef

  40. 40
    Hyun Jung Lee, Dae Young Kim, Bhumsuk Keam, Jeong Hoon Lee, Sae-Won Han, Do-Youn Oh, Jung Hwan Yoon, Tae-You Kim, Yu Jung Kim, Keun Wook Lee, Jin-Wook Kim, Sook-Hyang Jeong, Jong Seok Lee, Jee Hyun Kim, Seock-Ah Im, Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy, Breast Cancer, 2012,

    CrossRef

  41. 41
    Yi-Hsiang Huang, Han-Chieh Lin, Shou-Dong Lee, Management of chemotherapy-induced hepatitis B virus reactivation, Journal of the Chinese Medical Association, 2012, 75, 8, 359

    CrossRef

  42. 42
    Liang Huang, Jing Li, Wan Yee Lau, Jianjun Yan, Feiguo Zhou, Caifeng Liu, Xianghua Zhang, Jun Shen, Mengchao Wu, Yiqun Yan, Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma, Journal of Gastroenterology and Hepatology, 2012, 27, 1
  43. 43
    Manuel García-Bengoechea, Cándido Hernández-López, Javier Crespo, Francisco Gea, Prácticas de cribado del virus de la hepatitis B previo a las terapias de riesgo de reactivación vírica en diferentes especialidades médicas. Proyecto HEBRA, Medicina Clínica, 2012, 139, 11, 498

    CrossRef

  44. 44
    Makoto Oketani, Akio Ido, Hirofumi Uto, Hirohito Tsubouchi, Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy, Hepatology Research, 2012, 42, 7
  45. 45
    M. Joerger, A. D. R. Huitema, G. Illerhaus, A. J. M. Ferreri, Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma, Leukemia & Lymphoma, 2012, 53, 10, 1867

    CrossRef

  46. 46
    Harrys A. Torres, Marta Davila, Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer, Nature Reviews Clinical Oncology, 2012, 9, 3, 156

    CrossRef

  47. 47
    Liu Caifeng, Li Jing, Huang Liang, Yan Yiqun, Reactivation of hepatitis C virus replication in a patient undergoing hepatectomy for hepatocellular carcinoma, Journal of Medical Colleges of PLA, 2012, 27, 5, 306

    CrossRef

  48. 48
    D. H. T. Mya, S. T. Han, Y. C. Linn, W. Y. K. Hwang, Y. T. Goh, D. C. L. Tan, Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection, Annals of Oncology, 2012, 23, 2, 421

    CrossRef

  49. 49
    Ronald M. Bukowski, Temsirolimus : a safety and efficacy review, Expert Opinion on Drug Safety, 2012, 11, 5, 861

    CrossRef

  50. 50
    Jun-Ying Liu, Yun-Jian Sheng, Xiang-Chun Ding, Hui Tang, Shi-Wen Tong, Da-Zhi Zhang, Zhi Zhou, Peng Hu, Yong Liao, Hong Ren, Huai-Dong Hu, The efficacy of lamivudine prophylaxis against hepatitis B reactivation in breast cancer patients undergoing chemotherapy: A meta-analysis, Journal of the Formosan Medical Association, 2012,

    CrossRef

  51. 51
    Mitra Mirzaee, Ramin Yaghobi, Mani Ramzi, Mahdi Roshan Nia, The prevalence of molecular and immunologic infective markers of hepatitis viruses in patients with hematological malignancies, Molecular Biology Reports, 2012, 39, 2, 1217

    CrossRef

  52. 52
    Andres F Carrion, Paul Martin, Viral Hepatitis in the Elderly, The American Journal of Gastroenterology, 2012, 107, 5, 691

    CrossRef

  53. 53
    Meijun Long, Weijuan Jia, Shunrong Li, Liang Jin, Jiannan Wu, Nanyan Rao, Huiyi Feng, Kai Chen, Heran Deng, Fengtao Liu, Fengxi Su, Erwei Song, A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?, Breast Cancer Research and Treatment, 2011, 127, 3, 705

    CrossRef

  54. 54
    Xiang-Ming Lao, Dian Wang, Ming Shi, Guipeng Liu, Shengping Li, Rongping Guo, Yunfei Yuan, Minshan Chen, Jinqing Li, Yaqi Zhang, Xiaojun Lin, Changes in hepatitis B virus DNA levels and liver function after transcatheter arterial chemoembolization of hepatocellular carcinoma, Hepatology Research, 2011, 41, 6
  55. 55
    H.-R. Li, J.-J. Huang, H.-Q. Guo, X. Zhang, Y. Xie, H.-L. Zhu, L.-Z. Zhai, X.-X. Pu, Y. Huang, C.-C. Guo, T.-Y. Lin, Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy, Journal of Viral Hepatitis, 2011, 18, 12
  56. 56
    Pil Soo Sung, Si Hyun Bae, Jeong Won Jang, Do Seon Song, Hee Yeon Kim, Sun Hong Yoo, Chung-Hwa Park, Jung Hyun Kwon, Myeong Jun Song, Chan Ran You, Jong Young Choi, Seung Kew Yoon, Differences in the patterns and outcomes of enhanced viral replication between hepatitis C virus and hepatitis B virus in patients with hepatocellular carcinoma during transarterial chemolipiodolization, The Korean Journal of Hepatology, 2011, 17, 4, 299

    CrossRef

  57. 57
    Ramazan Idilman, Mutlu Arat, Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation, Expert Review of Anti-infective Therapy, 2011, 9, 8, 641

    CrossRef

  58. 58
    Carlo Marinone, Monica Mestriner, HBV disease: HBsAg carrier and occult B infection reactivation in haematological setting, Digestive and Liver Disease, 2011, 43, S49

    CrossRef

  59. 59
    Zhengang Sun, Gaopeng Li, Xi Ai, Baoming Luo, Yanling Wen, Zizhuo Zhao, Shengli Dong, Jian Guan, Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: Incidence, diagnosis, treatment, outcome and mechanism, Critical Reviews in Oncology/Hematology, 2011, 79, 2, 164

    CrossRef

  60. 60
    Samuel E Moses, ZiYi Lim, Mark A Zuckerman, Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients, Expert Review of Anti-infective Therapy, 2011, 9, 10, 891

    CrossRef

  61. 61
    Camillo Porta, Susanne Osanto, Alain Ravaud, Miguel-Angel Climent, Ulka Vaishampayan, Dorothy A. White, Patricia Creel, Brenda Dickow, Patricia Fischer, Suzanne Sweeney Gornell, Federica Meloni, Robert J. Motzer, Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma, European Journal of Cancer, 2011, 47, 9, 1287

    CrossRef

  62. 62
    Chiao-Fang Teng, Han-Chieh Wu, Hung-Wen Tsai, Her-Shyong Shiah, Wenya Huang, Ih-Jen Su, Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy, Hepatology, 2011, 54, 4
  63. 63
    J Yun, K H Kim, E S Kang, G-Y Gwak, M S Choi, J E Lee, S J Nam, J-H Yang, Y H Park, J S Ahn, Y-H Im, Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy, British Journal of Cancer, 2011, 104, 4, 559

    CrossRef

  64. 64
    Athina Pyrpasopoulou, Stella Douma, Themistoklis Vassiliadis, Sofia Chatzimichailidou, Areti Triantafyllou, Spyros Aslanidis, Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis, Rheumatology International, 2011, 31, 3, 403

    CrossRef

  65. 65
    Makoto OHNO, Yoshitaka NARITA, Yasuji MIYAKITA, Hideki UENO, Takamasa KAYAMA, Soichiro SHIBUI, Reactivation of Hepatitis B Virus After Glioblastoma Treatment With Temozolomide, Neurologia medico-chirurgica, 2011, 51, 10, 728

    CrossRef

  66. 66
    Shigeru Kusumoto, Yasuhito Tanaka, Ryuzo Ueda, Masashi Mizokami, Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy, Journal of Gastroenterology, 2011, 46, 1, 9

    CrossRef

  67. 67
    J. P. Gisbert, M. Chaparro, M. Esteve, Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, 2011, 33, 6
  68. 68
    A. M. Evens, B. D. Jovanovic, Y.- C. Su, D. W. Raisch, D. Ganger, S. M. Belknap, M.- S. Dai, B.- C. C. Chiu, B. Fintel, Y. Cheng, S.- S. Chuang, M.- Y. Lee, T.- Y. Chen, S.- F. Lin, C.- Y. Kuo, Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports, Annals of Oncology, 2011, 22, 5, 1170

    CrossRef

  69. 69
    Moonkyoo Kong, Seong Eon Hong, Byung-Ho Kim, Jinhyun Choi, Three Cases of Radiation-Induced Hepatitis B Virus Reactivation after Hepatic Tomotherapy: Case Report, The Journal of the Korean Society for Therapeutic Radiology and Oncology, 2011, 29, 1, 53

    CrossRef

  70. 70
    Irene N Rapti, Stephanos J Hadziyannis, Treatment of special populations with chronic hepatitis B infection, Expert Review of Gastroenterology & Hepatology, 2011, 5, 3, 323

    CrossRef

  71. 71
    L. Hamzaoui, N. Ben Mahmoud, A. Mzid, N. Jeridi, K. Siai, S. Chatti, M. M. Azzouz, Une ascite révélant un lymphome non hodgkinien de type B et une hépatite chronique virale B, Journal Africain d'Hépato-Gastroentérologie, 2011, 5, 2, 74

    CrossRef

  72. 72
    B. S. Sohn, J. H. Ahn, K. H. Jung, S.-H. Ahn, B. H. Son, G. Gong, S.-B. Kim, Updated Longitudinal Data on Acute Exacerbation of Chronic Hepatitis B in Patients With Breast Cancer Receiving Anthracycline-based Adjuvant Chemotherapy: Therapeutic vs. Pre-emptive Use of Lamivudine, Japanese Journal of Clinical Oncology, 2011, 41, 9, 1059

    CrossRef

  73. 73
    Kavitha Gopal, Albert D. Min, Chemoprevention of Patients with Hepatitis B Receiving Chemotherapy or Bone Marrow Transplant, Current Hepatitis Reports, 2010, 9, 3, 178

    CrossRef

  74. 74
    P. Borentain, P. Colson, D. Coso, E. Bories, A. Charbonnier, A. M. Stoppa, T. Auran, A. Loundou, A. Motte, E. Ressiot, E. Norguet, C. Chabannon, R. Bouabdallah, C. Tamalet, R. Gérolami, Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer, Journal of Viral Hepatitis, 2010, 17, 11
  75. 75
    Masaaki Watanabe, Akitaka Shibuya, Juichi Takada, Yoshiaki Tanaka, Yusuke Okuwaki, Tsutomu Minamino, Hisashi Hidaka, Takahide Nakazawa, Wasaburo Koizumi, Entecavir is an optional agent to prevent hepatitis B virus (HBV) reactivation: A review of 16 patients, European Journal of Internal Medicine, 2010, 21, 4, 333

    CrossRef

  76. 76
    Seong Min Chung, Joo Hyun Sohn, Tae Yeob Kim, Ki Deok Yoo, Yong Woo Ahn, Joong Ho Bae, Yong Cheol Jeon, Jung Hye Choi, Fulminant Hepatic Failure with Hepatitis B Virus Reactivation after Rituximab Treatment in a Patient with Resolved Hepatitis B, The Korean Journal of Gastroenterology, 2010, 55, 4, 266

    CrossRef

  77. 77
    Tomoki Aomatsu, Haruki Komatsu, Atsushi Yoden, Akiko Hosomi, Hiroshi Miyazaki, Tsuyoshi Sogo, Ayano Inui, Tomoo Fujisawa, Hiroshi Tamai, Fulminant hepatitis B and acute hepatitis B due to intrafamilial transmission of HBV after chemotherapy for non-Hodgkin’s lymphoma in an HBV carrier, European Journal of Pediatrics, 2010, 169, 2, 167

    CrossRef

  78. 78
    J.P. Power, M. El Chaar, J. Temple, M. Thomas, D. Spillane, D. Candotti, J.P. Allain, HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted Hepatitis B virus, Journal of Hepatology, 2010, 53, 4, 780

    CrossRef

  79. You have free access to this content79
    John S Lubel, Peter W Angus, Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management, Journal of Gastroenterology and Hepatology, 2010, 25, 5
  80. 80
    I-Cheng Lee, Yi-Hsiang Huang, Chi-Jen Chu, Pui-Ching Lee, Han-Chieh Lin, Shou-Dong Lee, Hepatitis B Virus Reactivation After 23 Months of Rituximab-based Chemotherapy in an HBsAg-negative, Anti-HBs-positive Patient With Follicular Lymphoma, Journal of the Chinese Medical Association, 2010, 73, 3, 156

    CrossRef

  81. 81
    BoKyong Kim, Hepatitis B Virus Reactivation after Partial Hepatic Irradiation Alone: A Case Report, The Journal of the Korean Society for Therapeutic Radiology and Oncology, 2010, 28, 2, 106

    CrossRef

  82. 82
    Luisa Giaccone, Moreno Festuccia, Andrea Marengo, Isabel Resta, Roberto Sorasio, Fabrizia Pittaluga, Francesca Fiore, Mario Boccadoro, Mario Rizzetto, Benedetto Bruno, Alfredo Marzano, Hepatitis B Virus Reactivation and Efficacy of Prophylaxis with Lamivudine in Patients Undergoing Allogeneic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, 2010, 16, 6, 809

    CrossRef

  83. 83
    Philip A. Thompson, Constantine S. Tam, Karin Thursky, John F. Seymour, Hepatitis-B reactivation and rituximab-containing chemotherapy: an increasingly complex clinical challenge, Leukemia & Lymphoma, 2010, 51, 9, 1592

    CrossRef

  84. 84
    Münci Yağcı, Zübeyde Nur Özkurt, Zeynep Arzu Yeğin, Zeynep Akı, Gülsan Türköz Sucak, Rauf Haznedar, Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies, Hematology, 2010, 15, 4, 240

    CrossRef

  85. 85
    Dongmei Ji, Junning Cao, Xiaonan Hong, Junmin Li, Jianmin Wang, Fangyuan Chen, Chun Wang, Shanhua Zou, Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study, European Journal of Haematology, 2010, 85, 3
  86. 86
    Hank S. Wang, Steven-Huy B. Han, Management of Hepatitis B in Special Patient Populations, Clinics in Liver Disease, 2010, 14, 3, 505

    CrossRef

  87. 87
    Eduardo Muñoz Bertrán, Elena Pérez Ceballos, Rosa Gómez Espín, Isabel Ortega González, Reactivación de la hepatitis B en un paciente HBsAg negativo/antiHBc positivo con linfoma B que recibió quimioterapia con rituximab, Gastroenterología y Hepatología, 2010, 33, 5, 377

    CrossRef

  88. 88
    Shigeru Kusumoto, Yasuhito Tanaka, Reply to the letter by Bedognetti et al. “Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era”, International Journal of Hematology, 2010, 91, 2, 345

    CrossRef

  89. 89
    Yutaka Tsutsumi, Reiki Ogasawara, Yusuke Kamihara, Shinichi Ito, Yoshiya Yamamoto, Junji Tanaka, Masahiro Asaka, Masahiro Imamura, Rituximab Administration and Reactivation of HBV, Hepatitis Research and Treatment, 2010, 2010, 1

    CrossRef

  90. 90
    R. Caporali, F. Bobbio-Pallavicini, F. Atzeni, G. Sakellariou, M. Caprioli, C. Montecucco, P. Sarzi-Puttini,